STEALTH-001
KaliVir Immunotherapeutics
KaliVir Immunotherapeutics
Pfizer
Tizona Therapeutics, Inc
Takeda
Kidney Cancer Research Bureau
Second Life Therapeutics
Novartis
University of Pittsburgh
Degron Therapeutics Co.
National Institutes of Health Clinical Center (CC)
UNC Lineberger Comprehensive Cancer Center
A2 Biotherapeutics Inc.
Washington University School of Medicine
Sensei Biotherapeutics, Inc.
Genentech, Inc.
Apollomics Inc.
ModeX Therapeutics, An OPKO Health Company
University of Alabama at Birmingham
Cancer Research UK
DEKA Biosciences
Columbia University
Elevation Oncology
RenJi Hospital
Rutgers, The State University of New Jersey
Universidade Federal de Pernambuco
Inhibrx Biosciences, Inc
European Organisation for Research and Treatment of Cancer - EORTC
Second Affiliated Hospital of Guangzhou Medical University
Washington University School of Medicine
Cedars-Sinai Medical Center
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Shanghai Yunying Medical Technology
Kineta Inc.
Quadriga Biosciences, Inc.
Ludwig Institute for Cancer Research
Imperial College London
Roswell Park Cancer Institute
Pfizer
Weill Medical College of Cornell University
Fate Therapeutics
Hospices Civils de Lyon
Sun Yat-sen University
Celgene
Osaka University
Instituto do Cancer do Estado de São Paulo
Stanford University
Amgen
Butler Hospital
Celldex Therapeutics